Today, weāre diving into a question almost everyone asks when they start thinking about weight loss: āWhatās the best diet for losing weight?ā And Iām going to tell you something straight away there isnāt one. Thereās no magic plan, no secret pill or injection, no ratio of carbs to fat that guarantees fat loss for […]
glp1
Why GLP-1 Weight Loss Can Slow
Today, weāre talking about something that can be both confusing and frustrating ā why weight loss can slow down on GLP-1 medications, and how other diabetes medications, like metformin or sulfonylureas, can play a role. Letās start with the weight loss medications themselves. Semaglutide is a GLP-1 receptor agonist. It mimics the bodyās natural GLP-1 […]
Fatigue on Semaglutide or Tirzepatide
If youāve started a GLP-1 medication and found yourself thinking, āWhy am I so tired all of a sudden?ā, youāre definitely not alone. Today, weāre talking specifically about fatigue with semaglutide and tirzepatideāwhat the research actually shows, why fatigue seems more common with some GLP-1s than others, and what you can do if your energy […]
Nutrient Tips While on GLPā1 Medications
Today weāre going to talk about something thatās becoming really important for anyone taking medications like Ozempic, Wegovy, or other GLPā1 receptor agonists. You probably already know the benefits of GLP-1sāsmaller appetite, better blood sugar control, and noticeable weight loss. But hereās the catch: eating less can sometimes mean youāre also taking in fewer essential […]
Finding the Right Fit: Semaglutide, Tirzepatide, or Retatrutide
Today, weāre tackling a question that comes up often in peptide, weight loss, and nutrition clinics: why does one person see great results with semaglutide, while another responds better to tirzepatideāor even retatrutide? All three peptides target the incretin system, but they act in slightly different waysāand those differences can dramatically affect outcomes. Letās start […]
GLP-1ās & Addiction
Today weāre talking about peptides being researched for addiction. Weāll unpack the science behind the incretin system, how those pathways tie into reward and substance use, and focus in on the newest tripleāagonist retatrutide. Weāll also look at early evidence for alcohol, tobacco and other substance-use disorders when using certain peptide therapies. What are GLP-1, […]